🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Liver Disease

GPC3 Targeted Fluorescence Image Guided Surgery of Hepatocellular Carcinoma NCT05047510NA2 sites📍 Zhuhai📍 Luzhou Chinese Academy of Sciences · Tests: Anti-GPC3-IRDye800CW An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response NCT04796818NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Diffusion Weighted Imaging Tislelizumab or Tislelizumab Combined With Lenvatinib Neo-adjuvant Treatment for Resectable RHCC NCT04615143Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Tislelizumab, Tislelizumab combined with Levatinib Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors NCT07106814EARLY Phase 11 site📍 Hefei Anhui Provincial Hospital · Tests: Metabolically Armed TIL cells New HBV Infection Biomarkers: Clinical Characterization and Impact on Management NCT06906016n/a1 site📍 Créteil Assistance Publique - Hôpitaux de Paris · Tests: Collection of blood samples for the study of HBV biomarkers A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer NCT06636435Phase 15 sites📍 Kashiwa📍 Yokohama📍 Niigata Chiome Bioscience Inc. · Tests: CBA-1205 Part 1, CBA-1205 Part 2, CBA-1205 Part 3, CBA-1205 Part 4, CBA-1205 Part 5 Comparison of Serum Myokine Dosages and Imaging Methods in the Evaluation of Sarcopenia in Patients With Hepatocellular Carcinoma NCT06475118NA1 site📍 Reims CHU de Reims · Tests: Dynamometry measurement, myokine dosing, sarcopenia calculation Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy NCT04096014NA1 site📍 Cleveland The Cleveland Clinic · Tests: Ensure Enlive, Standard Of Care Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease NCT07242222Phase 1, Phase 21 site📍 Tanta Tanta University · Tests: Standard Therapy, Erdosteine Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP) NCT07222813NA7 sites📍 Los Angeles📍 Minneota📍 Charleston Echosens · Tests: FibroScan, Right-sided Heart Catheterization, Transthoracic echocardiography, Blood Sample Analysis The COherence of Scatter Identification and Exclusion Algorithm Study NCT06975579n/a1 site📍 London Institute of Cancer Research, United Kingdom · Tests: Ultrasound image processing JMT106 Injection in the Treatment of Advanced Solid Tumors NCT07275073Phase 11 site📍 Zhejiang Shanghai JMT-Bio Inc. · Tests: JMT106 Injection Clinical Application of a Low-Dose CBCT AI Model NCT07845929NA5 sites📍 Hefei📍 Wuhan📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: DeepPriorCBCT-V2, Clinical standard protocol (Full-radiation-dose CBCT) A Multicenter Cancer Biospecimen Collection Study NCT04510129n/a1 site📍 San Francisco Cofactor Genomics, Inc. · Tests: OncoPrism™ assay Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy NCT06870942Phase 21 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: Maintenance first-line treatment plus radiation therapy A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy NCT03394365Phase 371 sites📍 Duarte📍 La Jolla📍 Loma Linda Pierre Fabre Medicament · Tests: tabelecleucel Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA NCT05797077Phase 31 site📍 Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University · Tests: Colorectal resection surgery., FOLFOX chemotherapy regimen, Capecitabine A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B NCT07389044Phase 15 sites📍 Hong Kong📍 Hong Kong📍 Chisinau IntegerBio · Tests: IB-001, Placebo, Peginterferon Alfa-2A Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients NCT05699018NA13 sites📍 Angers📍 Angers📍 Baugé-en-Anjou University Hospital, Angers · Tests: eLIFT ePro Diary - HDV ( MACROLIVER ) NCT07442760n/a1 site📍 Bergamo FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases NCT05240950Phase 11 site📍 Shanghai Changhai Hospital · Tests: Anti-CEA CAR-T Cells CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma NCT05257590Phase 25 sites📍 Kaohsiung City📍 Keelung📍 Tainan TaiRx, Inc. · Tests: Nivolumab Injection [Opdivo], CVM-1118 Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model NCT06420440Phase 22 sites📍 Xiangyang📍 Jinan Chen Xiaoping · Tests: Hepatic arterial infusion chemotherapy, Lenvatinib, Tislelizumab, Liver resection, Tislelizumab Surgical-imaging Research on Obesity (SIRO) NCT06268262n/a1 site📍 Xuzhou The Affiliated Hospital of Xuzhou Medical University Cirrhosis, Effects of TRAnsplantation and Diabetes NCT02038517n/a1 site📍 Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico A Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia NCT07681089Phase 24 sites📍 Sapporo📍 Sendai📍 Osaka Kiminori Kimura, MD · Tests: Foscenvivint Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors NCT07485114n/a1 site📍 Tel Aviv Daniel Keizman · Tests: Serum Gal-3 level, blood count and chemistry included liver function A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC NCT06294548Phase 1, Phase 21 site📍 Birmingham University of Alabama at Birmingham · Tests: Valemetostat, Atezolizumab, Bevacizumab A First in Human Study of PLT012 in Participants With Solid Tumor Cancers NCT07337525Phase 14 sites📍 Los Angeles📍 Dallas📍 Houston Pilatus Biosciences Inc · Tests: PLT012 Accurate Point of Care Liver Disease Diagnostics (Phase 2) NCT07518784n/a1 site📍 La Jolla University of California, San Diego · Tests: LiverScope® exam, MR exam, Blood draw, Body measurements, Questionnaire
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy